Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 242

    1.

    Hematocrit, independent of chronic kidney disease, predicts adverse cardiovascular outcomes in chinese patients with type 2 diabetes.

    Tong PC, Kong AP, So WY, Ng MH, Yang X, Ng MC, Ma RC, Ho CS, Lam CW, Chow CC, Cockram CS, Chan JC.

    Diabetes Care. 2006 Nov;29(11):2439-44.PMID: 17065681 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Prognostic effect of insertion/deletion polymorphism of the ace gene on renal and cardiovascular clinical outcomes in Chinese patients with type 2 diabetes.

    Wang Y, Ng MC, So WY, Tong PC, Ma RC, Chow CC, Cockram CS, Chan JC.

    Diabetes Care. 2005 Feb;28(2):348-54.PMID: 15677791 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Interactive effect of retinopathy and macroalbuminuria on all-cause mortality, cardiovascular and renal end points in Chinese patients with Type 2 diabetes mellitus.

    Tong PC, Kong AP, So WY, Yang X, Ng MC, Ho CS, Ma RC, Ozaki R, Ng V, Chow CC, Lam CW, Chan JC, Cockram CS.

    Diabet Med. 2007 Jul;24(7):741-6. Epub 2007 Apr 2.PMID: 17403120 [PubMed - indexed for MEDLINE]Related articles

    4.

    Anemia as a risk factor for cardiovascular disease and all-cause mortality in diabetes: the impact of chronic kidney disease.

    Vlagopoulos PT, Tighiouart H, Weiner DE, Griffith J, Pettitt D, Salem DN, Levey AS, Sarnak MJ.

    J Am Soc Nephrol. 2005 Nov;16(11):3403-10. Epub 2005 Sep 14.PMID: 16162813 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Glomerular filtration rate, cardiorenal end points, and all-cause mortality in type 2 diabetic patients.

    So WY, Kong AP, Ma RC, Ozaki R, Szeto CC, Chan NN, Ng V, Ho CS, Lam CW, Chow CC, Cockram CS, Chan JC, Tong PC.

    Diabetes Care. 2006 Sep;29(9):2046-52.PMID: 16936151 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Chronic kidney disease as a risk factor for coronary artery disease in Chinese with type 2 diabetes.

    Hsieh MC, Hsiao JY, Tien KJ, Chang SJ, Hsu SC, Liang HT, Chen HC, Lin SR, Tu ST.

    Am J Nephrol. 2008;28(2):317-23. Epub 2007 Nov 16.PMID: 18025781 [PubMed - indexed for MEDLINE]Related articles

    7.

    Metabolic syndrome predicts new onset of chronic kidney disease in 5,829 patients with type 2 diabetes: a 5-year prospective analysis of the Hong Kong Diabetes Registry.

    Luk AO, So WY, Ma RC, Kong AP, Ozaki R, Ng VS, Yu LW, Lau WW, Yang X, Chow FC, Chan JC, Tong PC; Hong Kong Diabetes Registry.

    Diabetes Care. 2008 Dec;31(12):2357-61. Epub 2008 Oct 3.PMID: 18835954 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Plasma concentration of asymmetric dimethylarginine (ADMA) predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy.

    Lajer M, Tarnow L, Jorsal A, Teerlink T, Parving HH, Rossing P.

    Diabetes Care. 2008 Apr;31(4):747-52. Epub 2007 Dec 27.PMID: 18162497 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Predictive cardiovascular risk factors in patients with chronic kidney disease (CKD).

    Goicoechea M, de Vinuesa SG, Gómez-Campderá F, Luño J.

    Kidney Int Suppl. 2005 Jan;(93):S35-8.PMID: 15613066 [PubMed - indexed for MEDLINE]Related articles

    10.

    Kidney disease as a risk factor for recurrent cardiovascular disease and mortality.

    Weiner DE, Tighiouart H, Stark PC, Amin MG, MacLeod B, Griffith JL, Salem DN, Levey AS, Sarnak MJ.

    Am J Kidney Dis. 2004 Aug;44(2):198-206.PMID: 15264177 [PubMed - indexed for MEDLINE]Related articles

    11.

    Effect of pioglitazone on cardiovascular outcome in diabetes and chronic kidney disease.

    Schneider CA, Ferrannini E, Defronzo R, Schernthaner G, Yates J, Erdmann E.

    J Am Soc Nephrol. 2008 Jan;19(1):182-7. Epub 2007 Dec 5.PMID: 18057215 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    The advanced glycation end product N(epsilon)-carboxymethyllysine is not a predictor of cardiovascular events and renal outcomes in patients with type 2 diabetic kidney disease and hypertension.

    Busch M, Franke S, Wolf G, Brandstädt A, Ott U, Gerth J, Hunsicker LG, Stein G; Collaborative Study Group.

    Am J Kidney Dis. 2006 Oct;48(4):571-9.PMID: 16997053 [PubMed - indexed for MEDLINE]Related articles

    13.

    Effect of pravastatin in people with diabetes and chronic kidney disease.

    Tonelli M, Keech A, Shepherd J, Sacks F, Tonkin A, Packard C, Pfeffer M, Simes J, Isles C, Furberg C, West M, Craven T, Curhan G.

    J Am Soc Nephrol. 2005 Dec;16(12):3748-54. Epub 2005 Oct 26.PMID: 16251235 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Intensive lipid lowering with atorvastatin in patients with coronary artery disease, diabetes, and chronic kidney disease.

    Shepherd J, Kastelein JP, Bittner VA, Carmena R, Deedwania PC, Breazna A, Dobson S, Wilson DJ, Zuckerman AL, Wenger NK; Treating to New Targets Steering Committee and Investigators.

    Mayo Clin Proc. 2008 Aug;83(8):870-9.PMID: 18674471 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Cardiovascular and renal outcome in subjects with K/DOQI stage 1-3 chronic kidney disease: the importance of urinary albumin excretion.

    Brantsma AH, Bakker SJ, Hillege HL, de Zeeuw D, de Jong PE, Gansevoort RT; PREVEND Study Group.

    Nephrol Dial Transplant. 2008 Dec;23(12):3851-8. Epub 2008 Jul 18.PMID: 18641082 [PubMed - indexed for MEDLINE]Related articles

    16.

    Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies.

    Weiner DE, Tighiouart H, Amin MG, Stark PC, MacLeod B, Griffith JL, Salem DN, Levey AS, Sarnak MJ.

    J Am Soc Nephrol. 2004 May;15(5):1307-15.PMID: 15100371 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    The case for chronic kidney disease, diabetes mellitus, and myocardial infarction being equivalent risk factors for cardiovascular mortality in patients older than 65 years.

    Rashidi A, Sehgal AR, Rahman M, O'Connor AS.

    Am J Cardiol. 2008 Dec 15;102(12):1668-73. Epub 2008 Oct 23.PMID: 19064021 [PubMed - indexed for MEDLINE]Related articles

    18.

    Aldose reductase genotypes and cardiorenal complications: an 8-year prospective analysis of 1,074 type 2 diabetic patients.

    So WY, Wang Y, Ng MC, Yang X, Ma RC, Lam V, Kong AP, Tong PC, Chan JC.

    Diabetes Care. 2008 Nov;31(11):2148-53. Epub 2008 Aug 20.PMID: 18716049 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    C-reactive protein and low albumin are predictors of morbidity and cardiovascular events in chronic kidney disease (CKD) 3-5 patients.

    Soriano S, González L, Martín-Malo A, Rodríguez M, Aljama P.

    Clin Nephrol. 2007 Jun;67(6):352-7.PMID: 17598370 [PubMed - indexed for MEDLINE]Related articles

    20.

    Asymmetric dimethylarginine predicts cardiovascular events in patients with type 2 diabetes.

    Krzyzanowska K, Mittermayer F, Wolzt M, Schernthaner G.

    Diabetes Care. 2007 Jul;30(7):1834-9. Epub 2007 Apr 24.PMID: 17456842 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data